CymaBay Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

2,380,105

Value ($000)

56,224

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	56,224	0.0%	2,380,105	12/31/2023
2023 Q3	11/13/2023	30,951	0.0%	2,075,556	9/30/2023
2023 Q2	8/11/2023	20,317	0.0%	1,855,470	6/30/2023
2023 Q1	5/15/2023	7,891	0.0%	904,958	3/31/2023
2022 Q4	2/13/2023	4,952	0.0%	789,914	12/31/2022
2022 Q3	11/14/2022	2,747	0.0%	784,965	9/30/2022
2022 Q2	8/12/2022	2,102	0.0%	712,578	6/30/2022
2022 Q1	5/13/2022	4,095	0.0%	1,316,948	3/31/2022
2021 Q4	2/11/2022	3,891	0.0%	1,151,205	12/31/2021
2021 Q3	11/12/2021	4,040	0.0%	1,107,091	9/30/2021
2021 Q2	8/13/2021	4,994	0.0%	1,145,605	6/30/2021
2021 Q1	5/12/2021	5,252	0.0%	1,156,974	3/31/2021
2020 Q4	2/12/2021	5,967	0.0%	1,039,565	12/31/2020
2020 Q3	11/13/2020	7,361	0.0%	1,016,750	9/30/2020
2020 Q2	8/13/2020	3,685	0.0%	1,056,003	6/30/2020
2020 Q1	5/14/2020	1,609	0.0%	1,087,183	3/31/2020
2019 Q4	2/13/2020	2,014	0.0%	1,027,920	12/31/2019